Form: Adverse Events
Question | Response |
---|---|
Adverse Event Verbatim | |
Event Category | |
Did the event start before administering first dose of study medication? | |
Date Started | |
Event ongoing? | |
Date Ended | |
Severity of the Event | |
Event Related to Study Drug | |
Toxicity Grade of the Event (CTCAE) | |
Action Taken with Study Drug because of Adverse Event | |
Other action taken? | |
Serious Event? | |
Resulted in Death? | |
Immediately Life Threatening? | |
Required Hospitalization or Prolonged Hospitalization? | |
If hospitalized, | |
date of hospitalization | |
Time of hospitalization | |
If hospitalized, | |
date of discharge | |
Time of discharge | |
Persistent or Significant Disability? | |
Congenital Anomaly/Birth Defect? | |
Other Medically Important Serious Event? | |
Outcome of the Event? | |
Was the event adjudicated | |
Adjudication Result | |
Relationship to Non-Study Treatment |
Form: Falls
Question | Response |
---|---|
Did the patient fall since last visit? | |
Date of fall | |
Time of the day | |
Environment (of fall) | |
Activity at the time of fall | |
Fall Mechanism | |
Did the fall result in injury | |
Severity of the injury | |
Form:
Question | Response |
---|---|
Did subject have any hypoglycemic events since the last visit? | |
Sequence Identifier | |
Hypoglycemic event start date | |
Hypoglycemic event start time | |
What was the date of last study treatment before the event? | |
What was the time of last study treatment before the event? | |
What was the subject's awareness of the hypoglycemic event? | |
Blood glucose concentration measured prior to treating the event? | |
If measured, what is the blood glucose concentration | |
Unit of blood glucose concentration measurement | |
Were signs/symptoms of hypoglycemia present, other than the blood glucos | |
What was the hypoglycemic event outcome? | |
Specify if outcome is other | |
Was treatment given because of the occurrence of the event? | |
If yes, how was the hypoglycemic event treatment | |
Form: Hepatobiliary assessment form
Question | Response |
---|---|
Adverse Event Identifier | |
Has the subject recently received a blood transfusion or traveled to an | |
Does the subject have signs or symptoms consistent with Hepatitis? | |
Has the subject recently experienced occupational or toxic exposure? | |
Has the subject had a recent increase in alcohol use? | |
Has the subject had a recent increase in recreational drug use? | |
Have any local labs been performed that pertain to this event? | |
Indicate the most severe Hepatobiliary AESI experienced by the Subject. | |
Has there been a serological evaluation for viral hepatitis A, B, or C, | |
Has a gastrointestinal or hepatobiliary consult occurred? | |
Did the patient have any other additional required procedures? | |
If yes, Specify the other additional required procedures | |
Form: Injection Site Reaction
Question | Response |
---|---|
Date of assessment | |
Did the subject have any injection site reacion events? | |
What is the date of the injection? | |
What date did the injection site reaction start? | |
At what time did the injection site reaction start? | |
What date did the injection site reaction end? | |
At what time did the injection site reaction end? | |
Was there pain (including burning) at the injection site? | |
Was there itching at the injection site? | |
Was there a rash (or redness) at the injection site? | |
Was there hardening (that includes a knot or lump) at the injection | |
Was there an open sore at the injection site? | |
What was the laterality of the anatomical location of the injection | |
What was the anatomical location of the injection site reaction? | |
Form: Chronic Kidney Diseaase History
Question | Response |
---|---|
Medical Condition | |
Date of diagnosis | |
Stage of Chronic Kidney Disease | |
What is the likely etiology of CKD? | |